baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Genetic Technologies Ltd/ US37185R4065 /

2024-05-10 8:36:14 PM	Chg. -0.08	Volume	Bid10:25:00 PM	Ask9:59:00 AM	High	Low
2.21USD	-3.49%	1,253 Turnover: 2,724.93	-Bid Size: -	-Ask Size: -	2.21	2.21

GlobeNewswire 12:00 PM Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...

GlobeNewswire 8:00 AM QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...

GlobeNewswire 7:00 AM Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chroni...

GlobeNewswire 05-10 Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024

GlobeNewswire 05-10 Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire 05-10 Axovia Therapeutics Announces Presentation of Preclinical Data Supporting Lead Program AXV-101 for T...

GlobeNewswire 05-09 4DMT Reports First Quarter 2024 Financial Results and Operational Highlights

GlobeNewswire 05-09 Rhythm Pharmaceuticals Announces New Employment Inducement Grants

GlobeNewswire 05-09 Genespire Presents Positive Preclinical Proof of Concept Data at the ASGCT Annual Meeting

GlobeNewswire 05-09 Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer

GlobeNewswire 05-09 Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the AS...

GlobeNewswire 05-09 Arbor Biotechnologies Presents Data Supporting Clinical Development of ABO-101 and Robust Potential ...

GlobeNewswire 05-08 Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly...

GlobeNewswire 05-08 Krystal Biotech to Present at BofA Securities 2024 Health Care Conference

GlobeNewswire 05-08 Arbor Biotechnologies Announces Acquisition of Serendipity

GlobeNewswire 05-08 Beam Therapeutics to Participate in RBC Capital Markets 2024 Global Healthcare Conference

GlobeNewswire 05-08 Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound G...

GlobeNewswire 05-08 Pharming Group reports first quarter 2024 financial results and provides business update

GlobeNewswire 05-07 Ultragenyx to Participate at Bank of America’s 2024 Healthcare Conference

GlobeNewswire 05-07 Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business

GlobeNewswire 05-07 4DMT to Participate in Upcoming Investor Conference

GlobeNewswire 05-07 Lexeo Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire 05-07 Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results

GlobeNewswire 05-07 EyeDNA Therapeutics Announces Positive 24-month Data Presented at ARVO from Ongoing Phase I/II Trial...

GlobeNewswire 05-06 GTG and ‘Wellworks for You’ sign B2B sales & marketing deal covering 750 employer groups and 2 milli...

Genetic Technologies Ltd/ US37185R4065 /

If you wish to receive reply to your feedback, please provide your email address.